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Abstract
The present study investigated the glycosylation state of proteins in lung tissue of a cyclophosphamide-induced model of
pulmonary fibrosis in rats. In fibrotic lung, the carbohydrate constituents (total hexose, fucose, sialic acid and hexosamine)
of salt-soluble, collagenase, elastase and papain digested glycoproteins were significantly higher compared to normal lungs.
Interestingly, fibrotic lung tissues had higher activities of mannosyl, glucosyl, galactosyl, sialyl and fucosyl transferases than
normal lung tissues. Similarly, mannosyl, glucosyl, galactosyl, sialyl and fucosyl transferases were higher in serum from rats
with fibrosis than in that from normals. These data indicate that glycoprotein metabolism is significantly altered from normal
in animals with interstitial lung fibrosis. z 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Interstitial pulmonary ¢brosis is a chronic in£am-
matory interstitial lung disease characterized by the
accumulation of alveolar macrophages and more
typically of neutrophils and lymphocytes in the lower
respiratory tract, followed by parenchymal injury
and ¢brosis of the alveolar structure [1]. Histopathol-
ogy of ¢brotic lung suggests that the lesions are rich
in extracellular matrix of connective tissue [2,3]. In
early stages of development, a marked ¢broblast in-
¢ltrate may be present, while at later stages the le-
sions are characterized by deposition of dense col-
lagenous meshwork. These observations suggest
that ¢brosis results from a localized loss of control
in the regulation of extracellular matrix production.
Lung growth, injury and repair are processes that
involve major changes in the extracellular matrix
and in the cells that produce this matrix [4]. In-
creased amounts and di¡erent types of collagenous
and non-collagenous components characterize the
end stages of lung ¢brosis [5^12]. The latter compo-
nents include glycoproteins which are predominantly
protein in nature with one or more heterosaccharide
chains containing hexosamines, hexoses, fucose and
sialic acid. These conjugated proteins are represented
by many substances of biologic importance, includ-
ing enzymes, hormones, antibodies and membranes.
The collagens, major structural proteins of the body,
have now been clearly shown to belong to the glyco-
protein family.
Whereas collagen, elastin and glycosaminoglycans
contents and synthesis in interstitial lung ¢brosis
have been reported [5^7,10^12], until now the nature
of changes in glycoproteins during the development
of lung ¢brosis is not very well understood.
Although this connective tissue component com-
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prises only a small percentage of the extracellular
matrix, it may nevertheless play an important role
in the pathogenesis of pulmonary ¢brosis by virtue
of its ubiquitous presence on cell surfaces and in the
extracellular matrix. It has been suggested that the
glycoproteins have some function in stabilizing the
tissue, and may be involved in maintaining the struc-
tural stability of collagen ¢brils [13]. Glycoproteins
incorporate into ¢brils during collagen synthesis and
play a role in cementing ¢brils into ¢bers, an inter-
action that accounts for certain biologic properties of
¢bers [14]. In addition, glycoproteins may be the
components of connective tissue that are primarily
responsible for its antigenic property in tissue trans-
plants [15]. Although carbohydrate moieties of gly-
coproteins are altered during the progression of lung
and liver ¢brosis [16,17], the nature of changes tak-
ing place in soluble glycoproteins, collagen and elas-
tin associated structural glycoproteins in ¢brotic con-
ditions and their importance have not been
completely elucidated until date. Furthermore, a spe-
ci¢c and precise analysis of the levels of glycopro-
teins (in this case carbohydrate moieties) and rele-
vant carbohydrate metabolic enzymes as a measure
of glycoprotein metabolism in normal lung and in
¢brotic conditions has not been studied previously.
Hence it became of interest to characterize the tem-
poral sequence of changes in the metabolism of lung
glycoproteins in experimental interstitial lung ¢brosis
induced by cyclophosphamide (CP). Cyclophospha-
mide has been observed to produce pulmonary ¢-
brosis in rats [18] and mice [19] after histologically
de¢nable periods of acute injury, cell death and in-
£ammation [20]. Since the pulmonary morphologic
and biochemical alterations induced by CP are sim-
ilar to those seen in man, we performed our inves-
tigations in this experimental model of lung ¢bro-
sis.
2. Materials and methods
2.1. Chemicals
Bacterial collagenase, L-mercaptoethanol, chloro-
form, elastase, methanol, ovomucoid, papain, sialic
acid, toluene, trichloroacetic acid and Triton X-100
were purchased from Sigma (St. Louis, MO, USA).
(GDP)-[14C]fucose, (UDP)-[14C]galactose, (UDP)-
[14C]glucose, (GDP)-[14C]mannose and (CMP)-
[14C]sialic acid were from Amersham International
(UK). Cyclophosphamide was obtained from Khan-
delwal Laboratories (India). All other chemicals used
were of analytical grade and commercially available.
2.2. Experimental design
Male albino rats of Wistar strain kept and inbred
in our animal house, weighing about 100 þ 10 g, were
used throughout this study. The rats were housed in
solid bottomed polyvinyl cages under controlled en-
vironmental conditions, i.e. 12 h photoperiod, tem-
perature (20 þ 2‡C) and humidity (60^70%). The ani-
mals received commercial pellets (Hindustan Lever,
Bombay, India) and water ad libitum.
Fibrosis was induced in pathogen-free, healthy
male rats by intraperitoneal injection of 20 mg/100
g body weight of CP. CP was given in a small vol-
ume of sterile triple distilled water. The control rats
were given the same volume of water only. Animals
were sacri¢ced (by decapitation under light ether
anesthesia) 7, 14, and 28 days after CP injection.
Immediately after sacri¢ce lung tissues were removed
on ice and processed for biochemical analysis. Blood
samples were allowed to clot and the serum was sep-
arated for quanti¢cation of enzymes. No statistically
signi¢cant di¡erences were observed between the dif-
ferent control groups on days 7, 14 and 28 on any
parameters analyzed and hence their pooled value
was used as control [17].
2.3. Assessment of lung ¢brosis
Lung ¢brosis was evaluated both histopathologi-
cally and biochemically. Lung hydroxyproline, a
classical marker of ¢brosis, was determined by the
method of Woessner [21]. Ten milligram of lung tis-
sue was hydrolyzed with 6 N hydrochloric acid for
20 h at 110‡C, evaporated to dryness, resuspended in
triple distilled water and made up to a known vol-
ume. The sample was treated with activated charcoal
and ¢ltered through Whatman ¢lter paper. The clear
¢ltrate was used for the determination of hydroxy-
proline. Two milliliter of samples containing 2^10 Wg
of hydroxyproline were placed in test tubes. Hydrox-
yproline oxidation was initiated by adding 1 ml of
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chloramine-T (0.141 g of chloramine-T in 2 ml of
triple distilled water, 3 ml of peroxide-free methyl
cellosolve and 5 ml of sodium acetate-citrate bu¡er,
pH 6.0) to each tube. The tube contents were vor-
texed for a few minutes and allowed to stand for
20 min at room temperature. The chloramine-T
was then destroyed by adding 1 ml of perchloric
acid to each tube. The contents were mixed and al-
lowed to stand for 5 min. Finally 1 ml of p-dimeth-
ylaminobenzaldehyde (20%, w/v, in methyl cello-
solve, freshly prepared before use) was added and
the mixture was shaken. The tubes were placed in a
60‡C water bath for 20 min, then cooled in tap water
for 5 min. The color developed was read spectropho-
tometrically at 557 nm.
2.4. Preparation of tissue and glycoprotein extraction
Glycoproteins were extracted from the lung sam-
ples as outlined in Fig. 1. Brie£y, the lungs were
dissected, rinsed in ice-cold 0.15 M NaCl to remove
blood and adherent tissues, weighed and ¢nely
minced with scissors. Tissues were homogenized in
0.15 M NaCl (15 ml/g tissue) using a Polytron ho-
mogenizer in the cold room at 4‡C. Homogenized
tissues were kept for shaking in a mechanical shaker
at 4‡C for 48 h and then allowed to stand for 3 h at
4‡C. Supernatants were separated and stored and the
residue was reextracted with 0.15 M NaCl. Pooled
supernatants were then dialyzed against 0.15 M
NaCl for 48 h at 4‡C and used for the estimation
of carbohydrate constituents of salt-soluble glyco-
proteins.
The residue after 0.15 M NaCl extraction was sub-
jected to collagenase (120 units/g tissue) digestion in
10 ml of 0.05 M Tris-HCl bu¡er, pH 7.4, containing
0.25 M calcium chloride and 1 mM PMSF, twice for
24 h each at 37‡C. The digested samples were centri-
fuged at 3000Ug to remove the residual material and
the supernatant was treated with 5% (w/v) trichloro-
acetic acid (TCA). The precipitate was separated,
dissolved in 0.2 M acetate bu¡er, pH 7.0, containing
2 mg cysteine hydrochloride and digested with crys-
talline papain (100 mg/g wet tissue) at 65‡C for 72 h.
The digested material was cooled to 4‡C and 4^5
vols. of ethanol were added and left for 24 h with
constant shaking and then centrifuged. The super-
natant was collected and evaporated to dryness
under vacuum. The dried residue was dissolved in
distilled water and used for the estimation of glyco-
proteins.
The residue after collagenase digestion was treated
thrice with elastase (0.5 mg/g wet tissue) in 0.2 M
Tris-HCl bu¡er, pH 8.8, containing 0.25 M calcium
chloride and 1 mM PMSF [22] and extraction was
repeated every 24 h. After each extraction, the super-
natants were separated by centrifugation at 3000Ug
and pooled. The elastase hydrolyzed proteins in the
pooled supernatants were precipitated with 5% TCA
and further extraction was carried out following the
same procedure as described under collagenase solu-
bilization using papain. The residue from the elastase
digestion was also subjected to papain digestion at
65‡C prior to assay for carbohydrate units of glyco-
proteins.
2.5. Estimation of fucose
Fucose content in the tissue homogenate was de-
termined utilizing the method described by Dische
and Shettles [23]. Aliquots of tissue homogenate
(1 ml) were added to 4.5 ml of cold sulfuric acid
and mixed vigorously. The samples were brought to
Fig. 1. Flow chart of the procedures for extraction of glycopro-
teins.
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room temperature, placed in a vigorously boiling
water bath (sample tubes must be capped) for exactly
3 min and then cooled to room temperature. Then
0.1 ml of cysteine reagent was added with immediate
mixing and the intensity of the color was determined
at 396 nm and at 427 nm in a Shimadzu UV-260
spectrophotometer. To avoid hexose interference
[17], the content of fucose in a given sample was
determined by subtracting the absorbance di¡erence
of the sample between 396 and 427 nm without cys-
teine from the absorbance di¡erence of the same
sample between 396 and 427 nm with cysteine.
2.6. Estimation of sialic acid
The content of sialic acid in tissue samples was
estimated using thiobarbituric acid as described by
Warren [24]. Since this assay measures only free sialic
acids [17], the tissue homogenates were hydrolyzed
with 0.1 N sulfuric acid at 80‡C for 60 min in a
sealed tube. The hydrolyzed samples were mixed
with 0.1 ml of periodate solution (0.2 M sodium
metaperiodate in 9 M phosphoric acid) and kept at
room temperature for 20 min. One milliliter of arse-
nite solution (10% sodium arsenite in a solution of
0.5 M sodium sulfate in 0.1 N sulfuric acid) was
added and the tubes were shaken until the yellow-
brown color of the liberated iodine disappeared.
Then 3 ml of the thiobarbituric acid solution (0.6%
thiobarbituric acid in a 0.5 mM sodium sulfate sol-
ution) was added and the contents were mixed thor-
oughly. The sample tubes were capped and heated in
a vigorously boiling water bath for 15 min and
cooled under tap water for 5 min. Finally 4.3 ml of
cyclohexanone was added and mixed vigorously in
order to extract the red color into the organic phase
and then centrifuged for 3 min at 1000Ug. The clear
top organic phase was transferred to a cuvette and
the intensity of the color was determined at 549 nm.
2.7. Estimation of total hexose
Total hexose was determined by the method of
Dubois et al. [25] using phenol as the speci¢c color
developing reagent. To aliquots of the tissue homo-
genates, 0.05 ml of the phenol reagent (80%, w/v, in
distilled water) was added. Then 5 ml of concen-
trated sulfuric acid was added rapidly and the sample
was brought to room temperature. The intensity of
the color was measured at 490 nm.
2.8. Estimation of hexosamine
Hexosamine in tissue homogenate was determined
following the procedure adopted by Boas et al. [26].
Since neutral sugars are present in tissue homoge-
nates, hexosamines were separated from neutral sug-
ars by adsorption and elution from ion-exchange res-
in (Dowex 50X4, 200^400 mesh H form). Prior to
the separation of hexosamines from the ion-exchange
column, hexosamines were liberated by acid hydrol-
ysis with 4 N HCl for 8 h in sealed tubes kept in a
boiling water bath. The acid from the hydrolyzate
was completely removed in a rotary evaporator
(Haake-Buchler PE6, Haake-Buchler Instruments,
Saddle Brook, NJ, USA) at 50‡C prior to placing
the samples on the ion-exchange column. The ion-
exchange resin was washed prior to use with 2 N
NaOH, distilled water, 3 N HCl and ¢nally with
distilled water, and transferred to the column. The
sample was loaded on the top of the column and
washed with triple distilled water. The hexosamines
were then eluted from the column with 2 N HCl and
the eluate was collected, evaporated to dryness at
50‡C and dissolved in a known amount of water.
One milliliter of this solution was mixed with 1 ml
of acetylacetone (2% solution in 1 N sodium carbo-
nate) in a screw capped tube and placed in a boiling
water bath for 45 min. After cooling, 2.5 ml of etha-
nol was added and mixed thoroughly. To this 1 ml of
Ehrlich’s reagent (2.67%, w/v, of p-dimethylamino-
benzaldehyde in a 1:1 mixture of ethanol and con-
centrated HCl) was added, mixed thoroughly and
made up to 10 ml with ethanol. The readings were
recorded at 530 nm.
2.9. Estimation of glycoprotein transferases
2.10. Microsome preparation
The lungs were minced with scissors and sus-
pended in 0.01 M Tris-HCl bu¡er, pH 7.5, contain-
ing 0.025 M potassium chloride, 0.005 M magnesium
chloride and 0.25 M sucrose. The suspension was
homogenized in a Polytron homogenizer. The homo-
genate was centrifuged at 12 000Ug for 10 min in a
Hitachi refrigerated centrifuge to sediment the cell
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debris, nuclei and mitochondria. The postmitochon-
drial supernatant was centrifuged at 105 000Ug for
60 min in an ultracentrifuge (Hitachi, Himac SCP
70G) to obtain the total microsome as a pellet. The
microsomes were suspended in Tris-HCl bu¡er and
used fresh for the assay of glycoprotein transferases.
2.11. Assay for mannosyl and glucosyl transferases
Mannosyl and glucosyl transferases were measured
following the procedure of Iusem et al. [27] with
slight modi¢cation. Microsomes for each resus-
pended in 200 Wl 0.25 M sucrose solution, pH 7.0,
containing 25 mM L-mercaptoethanol and 0.25 mM
EDTA were used as the enzyme source. A total vol-
ume of 50 Wl contained serum (20 Wl) or lung micro-
somes (25 Wl), containing 0.15 M sucrose, 77 mM
Tris-maleate, pH 7.7, 92 mM L-mercaptoethanol,
3 mM EDTA, 8.9 mM magnesium chloride, 0.5%
Triton X-100, dolichol phosphate and 2.8 WM GDP
[14C]mannose. The reaction was allowed to proceed
at 30‡C for 10 min and then terminated by adding
2 ml chloroform-methanol (3:2, v/v). After removal
of the protein pellet by low speed centrifugation, a
di¡erential extraction was performed [28]. The lower
phase was evaporated and its radioactivity taken as
an estimation of the amount of mannosylphosphoryl
dolichol formed. For analysis of UDP [14C]glucosyl
transferase the same procedure was followed except
that 0.86 WM UDP [14C]glucose was the sugar donor.
2.12. Assay for sialyl and galactosyl transferases
Sialyl and galactosyl transferase activities were as-
sayed as described by Fraser et al. [29]. A total vol-
ume of 50 Wl contained serum (20 Wl) or lung micro-
somes (25 Wl), 6 nmol CMP [14C]sialic acid, 6.25 nmol
MES (2-[N-morpholinoethanesulfonic acid) bu¡er,
pH 6.8 and 500 Wg desialofetuin and 0.5% Triton
X-100. Incubations were done at 37‡C for 60 min
and the reaction was terminated by the addition of
1 ml of 5% TCA/1% phosphotungstic acid (PTA)
mixture (1:1, v/v). Precipitates were ¢ltered under
suction through glass ¢ber ¢lters and washed with
10 ml TCA/PTA and 7 ml of ethanol/ether (1:1,
v/v). The discs were dried with ether and measured
for radioactivity in a toluene based scintillation so-
lution using a Beckman LS-1701 liquid scintillation
counter.
A total volume of 50 Wl contained serum (20 Wl) or
lung microsomes (25 Wl) as described above: 3 nmol
of UDP [14C]galactose, 6.25 nmol MES bu¡er, pH
6.8 and 250 Wg desialogalactofetuin. Assays were in-
cubated and processed for the measurement of radio-
active product as described above.
2.13. Assay for fucosyl transferase
Fucosyl transferase activity was assayed by the
method of Reddy et al. [30]. The lung tissues were
homogenized in 10 vols. of 50 mM (3-[N-morpholi-
nopropanesulfonic acid (MOPS), pH 6.8. The assay
system contained 50 mM MOPS bu¡er, pH 6.8,
20 WM GDP [14C]fucose, 4 mg of ovomucoid, 5 mM
magnesium chloride, 0.1% Triton X-100 and 75 Wg
equivalent of tissue homogenate or 0.5^0.7 mg serum
protein in a ¢nal volume of 50 Wl. The mixture was
incubated for 20 min at 37‡C. Blanks containing no
enzyme and zero time controls were used for suitable
corrections. Following incubation the tubes were
placed on ice to terminate the reaction and 2 ml of
cold TCA-PTA were immediately added and the
tubes were allowed to stand on ice for 10^15 min,
centrifuged and washed twice with TCA-PTA mix-
ture followed by one washing with 2 ml of ethanol-
ether (3:1, v/v). The washed precipitate was meas-
ured for radioactivity in a toluene based scintillation
solution.
The enzyme activity was expressed as nanomoles
per hour per 100 mg protein (serum) or micromoles
per hour per mg protein (tissue).
2.14. Statistical analysis
All data are presented as mean þ S.D. of six obser-
vations. The results were statistically evaluated using
Student’s t-test. Di¡erences were considered to be
statistically signi¢cant at the level of P6 0.05 and
P6 0.01.
3. Results
3.1. Characteristics of cyclophosphamide-treated rats
At a dose of 20 mg/100 g body weight, CP caused
a mortality rate of 25% that occurred between the
¢rst and second weeks of injection. Light micro-
scopic examination of the lungs of CP treated rats
revealed evidence of interstitial edema, presence of
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in£ammatory cell in¢ltrate with polymorphonuclear
leukocytes and macrophages and ¢broblastic masses
occupying alveolar spaces.
3.2. Lung hydroxyproline
The time course of the stimulation by CP of col-
lagen (determined as hydroxyproline) synthesis in rat
lung is shown in Fig. 2. A signi¢cant (P6 0.01) in-
crease in hydroxyproline content in the lung tissue of
CP rats was measured on day 14, and by day 28
hydroxyproline content was enhanced as much as
1.75-fold compared to controls. In contrast to the
stimulation of collagen synthesis caused by CP at
day 14 and day 28, no signi¢cant e¡ect on hydrox-
yproline content was observed at day 7. Further-
more, the stimulatory e¡ect of CP on collagen syn-
thesis appears to follow after the early increases in
carbohydrate constituents of glycoproteins.
3.3. Lung glycoprotein composition
The pro¢le of carbohydrate constituents of salt-
soluble and salt-resistant glycoproteins is shown in
Fig. 3 and Table 1, respectively. Quantitative com-
parison of carbohydrates between salt-soluble and
-insoluble fractions revealed that sequential proteo-
Table 1
Levels of carbohydrate constituents of collagenase, elastase and papain digested glycoproteins in the ¢brotic lung
Glycoproteins Control Day 7 Day 14 Day 28
Collagenase soluble
Total hexose 50.72 þ 2.68 58.75 þ 9.89* 66.20 þ 9.87** 69.90 þ 9.31**
Fucose 13.01 þ 1.38 21.67 þ 2.43** 21.51 þ 3.49** 24.72 þ 5.65**
Sialic acid 18.43 þ 0.95 29.22 þ 2.49** 27.11 þ 4.59** 33.81 þ 4.89**
Elastase soluble
Total hexose 33.85 þ 0.76 49.01 þ 8.64** 48.28 þ 5.46** 59.31 þ 5.90**
Fucose 12.63 þ 0.41 18.63 þ 2.40** 19.18 þ 2.91* 25.56 þ 4.29**
Sialic acid 16.76 þ 0.65 27.99 þ 2.16** 23.50 þ 4.65** 28.44 þ 6.79**
Papain soluble
Total hexose 33.80 þ 1.00 46.05 þ 7.87* 47.31 þ 5.10** 51.78 þ 8.94**
Fucose 9.23 þ 0.43 14.48 þ 3.44* 13.06 þ 2.21* 17.35 þ 3.42**
Sialic acid 23.01 þ 0.83 30.78 þ 3.50* 34.02 þ 5.32** 30.24 þ 7.18*
The residue after 0.15 M sodium chloride extraction was digested sequentially with collagenase, elastase and papain and the extracted
glycoprotein moieties were measured as described in Section 2. Results are expressed as mg/g protein. Values are expressed as
mean þ S.D. of six observations. Asterisks indicate values signi¢cantly higher than control values: *P6 0.05; **P6 0.01.
Fig. 2. Changes in hydroxyproline content in the lung during
the development of cyclophosphamide-induced lung ¢brosis.
Values shown are mean þ S.D. of six observations. *Signi¢-
cantly (P6 0.01) higher than control rats.
Fig. 3. Alteration in the levels of carbohydrate constituents of
salt-soluble glycoproteins extracted from ¢brotic lungs. Lung
tissues were rinsed in ice-cold 0.15 M sodium chloride, weighed,
minced, homogenized in 0.15 M sodium chloride and glycopro-
teins extracted and quantitated as described in Section 2. Re-
sults are expressed as mg/g protein. Values are mean þ S.D. of
six observations. #Signi¢cantly (P6 0.05) higher than controls.
*Signi¢cantly (P6 0.01) higher than control rats.
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lytic digestion with collagenase, elastase and papain
was responsible for the larger amount of glycopro-
teins released into the digested material of the lung
tissue. Biochemical analysis of carbohydrates re-
vealed that ¢brotic lungs contained signi¢cantly
(P6 0.01) more hexose, fucose and sialic acid than
did controls at days 7, 14 and 28. However, the in-
creases in carbohydrate constituents at 14 and 28
days were not as prominent as at day 7. In contrast,
¢brotic tissues demonstrated a progressive increase in
hexosamine content with increasing time. The signi¢-
cance of this observation implies an overall elevation
in the biosynthetic pathway leading to nucleotide
hexosamine formation as a result of in£ammation
[31], increased synthesis of glycoproteins containing
hexosamine, especially laminin [17,32,33], during the
early phase of wound healing and subsequent syn-
thesis of glycosaminoglycans [5^9,17]. A similar in-
crease in plasma ¢bronectin and perchlorosoluble se-
rum glycoproteins (determined as sialic acid) has
been reported in radiation-induced lung injury in
rats [34]. In addition, salt-soluble plasma glycopro-
teins have been noticed in wounds during the in£am-
matory phase [35,36]. Furthermore, increased fucose
content has also been reported in ¢brotic liver [17].
These observations suggest that the early increases in
carbohydrate moieties were due to an increased gly-
coprotein biosynthesis in response to the CP-induced
in£ammatory reaction. We believe that the increases
in carbohydrate constituents could be associated with
the activation of ¢broblasts to divide, proliferate and
synthesize non-collagenous glycoproteins and other
matrix constituents, a process mediated by a host
of substances which include immune complexes, se-
rum components, growth factors and cytokines, fol-
lowing tissue injury and during host in£ammatory
response [37,38].
3.4. Glycoprotein transferases
The activities of serum and lung glycoprotein
transferases are shown in Figs. 4 and 5, respectively.
Since several studies [29,32,39] have demonstrated an
association between enhanced glycoprotein biosyn-
thesis following in£ammation and changes in the ac-
tivities of enzymes involved in their synthesis, we
were particularly interested in determining whether
the tissue injury and in£ammation noticed after CP
insult were accompanied by an increase in glycopro-
tein transferases. In the present study, we investi-
gated glycoprotein transferases in serum and lung
tissues. First, we observed that CP treatment induced
an early increase in serum glycoprotein transferases
at day 7. Furthermore, we found a marked decrease
in these enzymes at day 14 and day 28, but their
Fig. 4. Quantitation of glycoprotein transferases in serum of ¢-
brotic rats. Results are expressed as nmoles/h/100 mg protein.
Data are mean þ S.D. of six observations. #Signi¢cantly
(P6 0.05) higher than controls. *Signi¢cantly (P6 0.01) higher
than control rats.
Fig. 5. Quantitation of glycosyltransferases in lung tissues of ¢-
brotic rats. Lung tissues were minced, suspended in Tris-HCl
bu¡er, homogenized and ultracentrifuged to obtain microsome
pellet. The microsomes were suspended in Tris-HCl bu¡er and
used for the assay of glycoprotein transferases as described in
Section 2. Results are expressed as micromoles/h/mg protein.
Values are mean þ S.D. of six experiments. #Signi¢cantly
(P6 0.05) higher than controls. *Signi¢cantly (P6 0.01) higher
than control rats.
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levels were still higher than in controls. Second, the
results presented here show that lung glycoprotein
transferase activities were elevated at day 7 and con-
tinued to rise until day 14, and then declined at day
28. In consideration of the above ¢ndings, it is clear
that the glycoprotein biosynthetic machinery is
switched on during the early in£ammatory phase of
wound healing.
4. Discussion
Our data demonstrate that changes in the pattern
of synthesis of glycoproteins in lung parenchyma oc-
cur shortly after cyclophosphamide administration.
Although the ¢brotic lung produced a higher propor-
tion of glycoproteins, 7 days after CP administration,
a substantial decrease in the amount of soluble gly-
coprotein content occurred thereafter at day 14 and
day 28 post CP. Interestingly, hexosamine levels were
elevated in the lungs of CP rats over a 4 week period.
The data reported herein demonstrate a signi¢cant
increase in various glycoprotein moieties such as to-
tal hexose, fucose, sialic acid and hexosamine as re-
covered from salt-soluble, collagenase, elastase and
papain digested fractions of ¢brotic tissues compared
to that of control. This is in agreement with the
results of most of the studies which have demon-
strated alterations in glycoprotein concentration dur-
ing in£ammatory conditions, liver ¢brosis, malig-
nancy and in tumorous human lung tissue [17,40^
44]. In order to obtain the carbohydrate portion of
a glycoprotein with a minimum number of amino
acids attached, it is essential to digest extensively
with a protease of low speci¢city. Papain is used
e¡ectively for the extensive digestion of the peptide
portion of glycoproteins. In order to achieve sequen-
tial release of sugars from collagen and elastin asso-
ciated structural glycoproteins, it is necessary to di-
gest sequentially with collagenase and elastase [22]. It
could be inferred from the present investigation that
not all the glycoproteins are recovered under 0.15 M
NaCl extraction and some of the glycoproteins are
intimately associated with collagen and elastin. The
use of two or more proteolytic enzymes in succession
is useful in achieving maximal shortening of the pep-
tide chains. The results reported have indicated that
digestion with collagenase and elastase is potentially
e⁄cient in solubilizing some of the insoluble glyco-
proteins associated with collagen and elastin and
provide more information regarding the glycoprotein
moieties associated with these connective tissue pro-
teins. After digestion with these enzymes it may be
useful to further reduce the length of peptide chains
by digesting with papain. Thus the use of two or
more of these enzymes resulted in a high recovery
of the carbohydrate material.
A greater increase in total hexose in the collagen-
ase digested fraction was observed. However, this is
not surprising in view of altered collagen synthesis in
¢brotic conditions [5,45^48]. It is also evident that
hexoses are associated more directly with collagen
as compared to hexosamine or sialic acid [49] and
the increase in the concentration of total hexose
may be explained in the presence of increased colla-
gen content and synthesis in ¢brotic conditions.
Higher than normal levels of hexosamine were found
in ¢brotic lungs. This seems likely to be the result of
enhanced synthesis of hexosamine by ¢brotic lungs.
The increase in hexosamine content may be inter-
preted on the basis of increased levels of glycosami-
noglycans in lung ¢brosis. Changes in glycosamino-
glycans (hexosamine and uronic acid, components of
glycosaminoglycans) content have been associated
with lung ¢brosis [5^9]. These studies along with
the present work demonstrate that altered glycopro-
tein synthesis is expected to have consequences for
the organization of collagen in the tissue, because it
is well known to in£uence collagen ¢bril morphology
and associations of ¢brils to ¢bers and ¢ber bundles
[13,14,50].
It must be emphasized that increases in carbohy-
drate constituents were more pronounced at day 7
compared to days 14 and 28. However, at later stages
in the ¢brotic phase the magnitude of increases in
carbohydrates were less than that seen for collagen.
It is also clear that there are increases in carbohy-
drate constituents in the collagenase soluble fraction
at day 7 despite no change in collagen content. It is
likely that collagenase soluble fractions contain other
non-collagenous glycoproteins. Our data demon-
strate that distinct metabolic changes occur during
tissue repair and ¢brosis in the lung. In early phases
of ¢brotic conditions, marked increases in glycopro-
teins occur. Subsequently, increased levels of colla-
gen occur in the late ¢brotic phase. Thus the di¡er-
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ences in temporal pattern between glycoproteins and
collagen synthesis is consistent with the concept that
non-collagenous insoluble structural glycoproteins
are produced during the early phase of wound heal-
ing. Our results are similar to those of previous stud-
ies that have examined the metabolism of non-col-
lagenous glycoproteins during wound healing [51,52].
Dolynchuk and Bowness [51] have demonstrated that
healing wounds synthesize maximum non-collage-
nous insoluble glycoproteins before the peak in col-
lagen synthesis. Interestingly, ¢bronectin (fucosyl-
ated) is involved in the organization of connective
tissue matrices, because it not only binds to collagen
and glycosaminoglycans, but also acts as a sca¡old
for collagen deposition and has many postulated
functions in wound healing [53,54]. In addition, other
glycoproteins, namely SPARC (secreted protein
acidic and rich in cysteine), tenascin and thrombo-
spondin, are all expressed in pulmonary ¢brosis [55].
We can therefore suggest that the marked early in-
creases in lung glycoprotein content re£ect an early
in£ammatory tissue remodeling phase in the process
of lung ¢brosis rather than the degree of established
end stage disease.
The investigation of the sugar units of glycopro-
teins has shown evident changes, especially in the
concentrations of hexosamine, fucose, sialic acid
and hexose, the augmentation of which is propor-
tional to the increase in the concentration and syn-
thesis of corresponding glycoprotein synthesizing en-
zymes. The observed increases in glycoprotein
moieties may be interpreted on the basis of elevated
levels of the relevant enzymes in the in£amed state. It
must be assumed that the initial response to in£am-
mation is the release of some active substance from
the site of in£ammation as suggested by Koj [56].
The active substance must operate at the site of syn-
thesis resulting in an increase in synthesis rates,
changes in tissue and circulating levels of enzymes
involved in the synthesis of carbohydrate portions
of glycoprotein, viz. mannosyl, glucosyl, galactosyl,
sialyl and fucosyl transferases, would tend to support
the above hypothesis. Investigations on the e¡ect of
in£ammation on glycoprotein transferases showed a
1.7^3.5-fold increase over a 14 day period as a result
of cyclophosphamide injection. It is of great interest
that the activity increases sharply during the ¢rst 14
days (lung glycoprotein transferases) after CP insult
and then declines progressively from 14 to 28 days
after injection; however, serum glycoprotein transfer-
ases peaked at day 7 and declined thereafter. Fraser
et al. [29] have demonstrated increased sialyl and
galactosyl transferase activity in the serum and liver
of in£amed rats. Lombart et al. [39] reported that the
activity of glucosyl transferase and the rate of trans-
port of N-acetylglucosamine, galactose and sialic
acid to an appropriate sugar depleted acceptor gly-
copeptide were increased during the process of in-
£ammation. In addition, increased levels of dolichol
phosphokinase activity and dolichol phosphate
linked glycosylation for mannose and glucose in the
liver of in£amed rats have been demonstrated. From
the foregoing observations it is evident that enzymes
involved in the biosynthesis of glycoproteins are al-
tered during in£ammation. It has to be stressed here
that there are no other reports on glycoprotein trans-
ferases in experimental lung damage; however, ani-
mals with chemically induced liver injury show in-
creased levels of these enzymes [29].
In summary, our results are the ¢rst to demon-
strate that the synthesis of glycoproteins is increased
greatly in ¢brotic lungs and suggest that they are
sequelae of an in£ammatory process during the de-
velopment of ¢brosis. The present work also sup-
ports the concept that signi¢cant metabolic activity
precedes the period of maximum collagen production
during in£ammatory conditions and that non-colla-
genous insoluble structural glycoproteins are pro-
duced during the early phase of ¢brosis or wound
healing.
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